Clincosm LogoSign in Get a demo

mycosis fungoides

Showing 26 - 50 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)

Completed
  • Cutaneous T Cell Lymphoma
  • +2 more
  • Leeds, United Kingdom
    Covance Clinical research Unit Ltd.
Feb 3, 2022

Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)

Not yet recruiting
  • Mycosis Fungoides
  • Cutaneous T Cell Lymphoma
  • Low-dose total-skin electron-beam therapy
  • Phototherapy
  • (no location specified)
Jan 24, 2022

Patients With Mycosis Fungoides and Sézary Syndrome.

Recruiting
  • Mycosis Fungoides
  • Sezary Syndrome
  • Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
  • Lund, Sweden
    Lund University Hospital
May 21, 2021

Mycosis Fungoides Trial (3.75% Imiquimod Cream, 0.1% Fluocinonide Cream)

Withdrawn
  • Mycosis Fungoides
  • 3.75% Imiquimod Cream
  • 0.1% Fluocinonide Cream
  • (no location specified)
Apr 23, 2021

T Cell Repertoire Analysis of Immune Mediated Skin Diseases

Completed
  • Psoriasis
  • Mycosis Fungoides
    • Sacramento, California
      University of California, Davis Department of Dermatology
    Mar 3, 2021

    Primary Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma Trial in Worldwide (Brentuximab

    Completed
    Has Results
    • Primary Cutaneous Anaplastic Large Cell Lymphoma
    • +2 more
    • Brentuximab Vedotin
    • +2 more
    • Los Angeles, California
    • +40 more
    Dec 16, 2020

    Solid Tumors, Mycosis Fungoides, Melanoma Trial in United States (TTI-621 Monotherapy, TTI-621 + PD-1/PD-L1 Inhibitor, TTI-621 +

    Terminated
    • Solid Tumors
    • +7 more
    • TTI-621 Monotherapy
    • +4 more
    • Duarte, California
    • +6 more
    May 13, 2020

    Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)

    Terminated
    • Non-Hodgkin's Lymphoma
    • +4 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 12, 2020

    Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)

    Completed
    Has Results
    • Mycosis Fungoides
    • Sezary Syndrome
    • A matched peripheral donor stem cells
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 2, 2020

    Mycosis Fungoides Trial in United States (Valchlor)

    Completed
    Has Results
    • Mycosis Fungoides
    • Little Rock, Arkansas
    • +35 more
    Feb 21, 2020

    Mycosis Fungoides, Cutaneous T-Cell Lymphoma, Tumors Trial run by the NCI (Romidepsin (FR901228))

    Terminated
    • Mycosis Fungoides
    • +2 more
    • Romidepsin (FR901228)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    Mycosis Fungoides, Sézary Syndrome Trial in Richmond (TSEB Therapy, Brentuximab vedotin)

    Completed
    • Mycosis Fungoides
    • Sézary Syndrome
    • TSEB Therapy
    • Brentuximab vedotin
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    Aug 29, 2019

    Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides, Sézary Syndrome Trial in Stanford, New York, Philadelphia (NM-IL-12 and

    Unknown status
    • Cutaneous T Cell Lymphoma (CTCL)
    • +2 more
    • NM-IL-12 and TSEBT
    • Stanford, California
    • +2 more
    Nov 14, 2018

    Lymphoma, T-Cell, Mycosis Fungoides, Hematologic Tumors Trial in Houston (Isotretinoin (Accutane), Interferon Alpha)

    Completed
    • Lymphoma, T-Cell
    • +2 more
    • Isotretinoin (Accutane)
    • Interferon Alpha
    • Houston, Texas
      M. D. Anderson Cancer Center
    Oct 25, 2018

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in United States (Methoxsalen+ECP)

    Completed
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • Chicago, Illinois
    • +6 more
    Aug 15, 2018

    Mycosis Fungoides Trial in Philadelphia (Mechlorethamine Hydrochloride Gel, Total Skin Electron Beam Radiation Therapy)

    Withdrawn
    • Mycosis Fungoides
    • Mechlorethamine Hydrochloride Gel
    • Total Skin Electron Beam Radiation Therapy
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 25, 2018

    Vietnam Cryptococcal Retention in Care Study - Version 2.1

    Unknown status
    • HIV/AIDS
    • +5 more
    • Preemptive high-dose Fluconazole
    • Hanoi, Vietnam
      National Hospital for Tropical Diseases
    Sep 10, 2017

    Non-Hodgkin Lymphoma (NHL), Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford (Brentuximab vedotin)

    Completed
    Has Results
    • Non-Hodgkin Lymphoma (NHL)
    • +4 more
    • Brentuximab vedotin
    • Stanford, California
      Stanford University School of Medicine
    Feb 17, 2017

    Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides Trial (MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA)

    Completed
    • Cutaneous T-cell Lymphoma
    • +2 more
    • MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA) / Duration of Treatment 6 Months
    • (no location specified)
    Apr 3, 2017

    Mycosis Fungoides Trial (CPG 7909)

    Withdrawn
    • Mycosis Fungoides
    • CPG 7909
    • (no location specified)
    Nov 29, 2016

    T-cell Lymphomas, T-cell Leukemia, Sezary Syndrome Trial in United States (A-dmDT390-bisFv(UCHT1))

    Completed
    • T-cell Lymphomas
    • +4 more
    • A-dmDT390-bisFv(UCHT1)
    • New Haven, Connecticut
    • +4 more
    Nov 28, 2016

    Mycosis Fungoides Trial (A-dmDT390-bisFv(UCHT1), Vorinostat)

    Unknown status
    • Mycosis Fungoides
    • (no location specified)
    Oct 21, 2016

    Mycosis Fungoides, Cutaneous T-cell Lymphoma Trial (Total skin electron beam therapy (TSEBT), mechlorethamine gel 0.016%)

    Unknown status
    • Mycosis Fungoides
    • Cutaneous T-cell Lymphoma
    • Total skin electron beam therapy (TSEBT)
    • mechlorethamine gel 0.016%
    • (no location specified)
    Aug 29, 2016

    Cutaneous and Hematologic Disorders by High-Throughput Nucleic

    Terminated
    • Cutaneous Lymphoma
    • +3 more
      • Stanford, California
        Stanford University, School of Medicine
      Jun 22, 2016

      Atopic Dermatitis, Psoriasis, Alopecia Trial in Ann Arbor (UVA1 Irradiation, UVB Irradiation)

      Terminated
      • Atopic Dermatitis
      • +6 more
      • UVA1 Irradiation
      • UVB Irradiation
      • Ann Arbor, Michigan
        University of Michigan Department of Dermatology
      May 21, 2015